Global Genetic Testing Market Statistical:
The Global Genetic Testing Market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The Global Genetic Testing Market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2009
The Global Genetic Testing Market is growing with the rapid pace. According to a recent study report published by the Market Research Future, the Global Genetic Testing Market is booming and expected to gain prominence over the forecast period and is projected to grow a sound pace. The market is projected to demonstrate a sound growth by 2023, surpassing its previous growth records in terms of value with a sound CAGR during the anticipated period (2017-2023).
Genetic testing involves various medical test that help us identify changes in chromosomes, genes, or proteins. The genetic tests can confirm or rule out a suspected genetic condition and it can help determine a person’s probability of developing a genetic disorder or passing on the same to next generation. Currently there are more than 1,000 genetic tests in use, and more are being developed. Rising awareness about the benefits of genetic testing, rising prevalence of the genetic disorders, changing trend in the industry from service driven to product driven industry are some of the factors that drives the market growth during the forecast period. However, limitations in the genetic testing and inaccuracy of tests, stringent regulation from the Insurance companies, and high cost of the tests are the major restraining factor for the market growth during the forecast period.
Key Players for Global Genetic Testing Market:
Abbott Laboratories, Bio-Rad Laboratories, Inc., Illumina Inc., Myriad Genetics, PerkinElmer Inc., QIAGEN N.V., and Quest Diagnostics
Global Genetic Testing Market has been segmented on the basis of type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016. On the basis of method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016. On the basis of type of test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016. On the basis of indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.
Get Quality [email protected]
Regional Analysis of Global Genetic Testing Market:
Considering the global scenario of the market, due to continuous innovation, high awareness about the genetic testing and rapid adoption of new technology, Americas is largest market and was holding 46.3% market share of global Genetic testing in 2016. US is holding largest market share in North America region. European genetic testing market is expected to reach USD 2,553.10 million by 2023. On the other hand, due to increasing aging population and advances in the medical fields, the Asia-Pacific (APAC) is fastest growing market for Genetic testing and expected to grow at a CAGR of 10.1% during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness and lack of required infrastructure.
TABLE OF CONTENTS:
1 Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
Reports Enquiry @ https://www.marketresearchfuture.com/enquiry/2009